• X-Ray Detectors Market Inclined to Deliver Positive Growth Results until 2023 - The growing technological advancement and increasing geriatric population will fuel the growth of the global x-ray detectors market. The increasing incidences of orthopedic, increasing use of imaging technology, and cardiovascular procedures will drive the growth of global x-ray detectors market. The introduction of effective x-ray devices such as filmless imaging machines will fuel the growth of the market. Better image quality and decreased cost will drive the growth of the market. Increasing support from governments in the funding process will also help drive the growth of the market. Extensive research and development will lead towards progress and development of x-ray detector devices, which in turn will fuel their demand and adoption rates. Read Report Overview: https://www.transparencymarketresearch.com/xray-detectors-market.html It is estimated that emerging economies such as Brazil, China, and India will prove to be lucrative markets for x-ray detector devices. Increasing geriatric population, growth in the awareness level regarding radiography systems, and increasing support from the government are some of the driving forces for the of x-ray detector devices market in these countries. Innovations such as the development of wireless x-ray detector devices have created a positive impact in the growth of the market. The growing medical tourism in these nations is also expected to push the growth of this market. However, the high cost of these systems will pose a challenge. Stringent regulatory procedures for approval process are another challenge for market players. In addition to this, a lack of skilled technicians in developing nations may also be a cause of worry. However, the escalating rise in the incidences of chronic diseases will ensure the continued demand for x-ray detector devices. X-ray detectors are used majorly for two purposes – imaging and dose measurement. Analog X-ray systems used photographic plates and films for image detection. However, owing to a shift in technology from analog to digital X-ray systems, the photographic plates and films are rapidly replaced by digital image plates (flat panel detectors). Flat panel detectors are highly sensitive and faster than a photographic film. With improving technology and rising demand for digital X-ray systems, the X-ray detectors require more robust structure with high transmission capability and temperature endurance, and resistant to ionizing radiations. The global X-ray detector market is analyzed based on the different types of detectors used in the X-ray devices. This includes flat panel detectors, charge coupled device (CCD) detectors, image intensifiers, line-scan detectors and computed radiography (CR) detectors. A rapid increase in demand for digital X-ray systems has led to incorporation of newer detection technologies such as flat panel detectors and charge coupled device (CCD) detectors. Moreover, with further advancement in research, an X-ray machine can have a large area or small area flat panel detector. A difference in the size of detector matters for different applications or subjects to be scanned. Advance fluoroscopy and C-arm systems incorporate flat panel detectors. Other X-ray detectors available in the market include gas ionization detectors, scintillation, gas-filled detectors, semiconductor detectors and gas electron multiplying detectors. Further, based on the applications or end-use, the global X-ray detectors market is categorized into dental, medical, veterinary, industrial, and security applications market. Medical applications include general radiography, surgical imaging, cardiovascular imaging and mammography. Geographically, the global X-ray detectors market is segmented into North America, Europe, Asia Pacific and Rest of the World. The market for X-ray detectors will be growing rapidly in the regions where the demand for X-ray systems is increasing. This basic fact marks the potential of X-ray detectors in Asia Pacific and Latin America regions where along with the demand for X-ray systems, manufacturing capacity is also increasing. Increasing adoption of digital X-ray systems is touted to fuel the demand for X-ray detectors in Asia Pacific. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11870 Further, emerging economies such as India, China, Brazil, Russia and Mexico are target markets for companies offering X-ray equipment owing to rapidly growing economy and presence of untapped opportunities in these countries. GE Healthcare bought a Brazilian X-ray equipment firm Xpro in 2012 to increase its market presence in the Latin America region. Some of the key players present in the global X-ray detectors market include Varian Medical Systems, PerkinElmer, Inc., Agfa Healthcare, Analogic Corporation, Canon Inc., Konica Minolta, Inc., Teledyne Technologies, Inc., Thales Group and Fujifilm Medical Systems and others. Intense competition is compelling market players to innovate in their product and marketing strategy. Teledyne Technologies, Inc. introduced two new models of X-ray detector Shad-o-Box 3K HS and Shad-o-Box 6K HS in March 2014, which utilizes latest generation CMOS X-ray technology offering higher resolution and faster imaging of objects. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Wed Feb 06 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Cardiac Problem Patient Airlifted Ranchi to Delhi by Global Air Ambulance - Yesterday 5 February 2019 one Cardiac problem patient whose name was Sandhya Srivastava and her age was 55 years was shifted from Medica hospital Ranchi to Medanta Hospital Delhi by Global Air Ambulance. She was very much serious and needed to be given an emergency treatment to be recovered soon. Before Reading this press release you really need to know what is Cardiac problem Cardiovascular disease symptoms may be different for men and women. For instance, men are more likely to have chest pain; women are more likely to have other symptoms along with chest discomforts, such as shortness of breath, nausea and extreme fatigue. Yesterday whom we transfer by Global Air Ambulance from Ranchi to Delhi was quite serious and she really needed to be given the best service and she needed to be transferred from Medica Hospital to Medanta Hospital. She was kept under observation under with MBBS and MD doctors, one experienced Paramedic, two attendants, and whole Medical team. She was provided with all the advanced and the newest medical equipment which includes ICU, CCU, Ventilator, Respirator, Oxygen, pacemakers, medications, ventilators, ECGs and monitoring units, CPR equipment, scoop stretchers, wheelchairs, and inducts drugs and medicines as required. Why His family booked Global Air Ambulance Service from Guwahati:- • 100% surety and quality based services • No extra charging and hidden cost • Booking available anytime through net or online • advanced and effective ICU medical team • Ready to pay its services every time as it is possible • approaching all over India and abroad also Recently we transferred one more Patient by Global Air Ambulance from Guwahati to Vellore and his name was Bimal Kumar and it was an accidental case and because of our fast service by Global Air Ambulance, his life was saved. If you want an Air Ambulance to Shift your loved one immediately then call us now and book and give your love one fastest service. More@ https://www.globalairambulance.in/air-ambulance-services-in-guwahati/ (Added: Wed Feb 06 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• How Spanish Eye Clinic Can Transform Your Vision And Improve The Quality Of Life - The Spanish Eye Clinic Address: 119, McLaren Building, Sheikh Zayed Road, Umm Al Sheif, Dubai Tel: +971 4 324 3244 Email: info@spanisheyeclinic.com Poor vision causes low quality of life. It is a challenge to lead a life where one cannot see the world and everything in it clearly. While prescription glasses and contact lenses may assist a person’s vision to a great extent, they also come with certain difficulties. In order to enjoy vision that improves the quality of life, the cataract surgeon in Dubai provides the highest standard of vision treatment. If anyone has been putting off getting treatment for their eyes, now is the time to do it. The longer the wait, the worse the vision can become. “Make 2019 the year to enjoy clear vision, let it be something you reward yourself with”, says Dr. Sonia Amoros from The Spanish Eye Clinic. Lasik treatment corrects multiple vision problems from shortsightedness, longs-ightedness and astigmatism. The Spanish Eye Clinic has a team of specialist eye surgeons that can enable patients to regain their original vision. It is a simple surgery that takes just 10 minutes per eye. Patients can return back to their daily routine, including their work life in just 24 hours. The only advice bestowed on patients is to avoid driving and swimming for the first two weeks, post-surgery. When there is a simple eye surgery that will completely transform a patient’s vision and enable them to lead happier and healthier lives, Dr. Sonia Amoros advises her patients to undergo the treatment at the Spanish Eye Clinic. It will lead to improved quality of life, she says. About Us The Spanish Eye Center is an outstanding refractive surgery center which specializes in Lasik treatment and cataract surgery. We offer unmatched treatment and care at a reasonable cost. If you want to know whether you make a good candidate for any of our vision treatment procedures, you can visit our clinic and consult with our professional and trained staff. The treatment and procedures are performed on-site to ensure your comfort and convenience. We use state of the art technology and the unmatched experience and expertise of our specialist eye surgeons, our patients are offered many choices to correct vision problems ensuring the best possible results. For more information, visit our website on https://www.spanisheyeclinic.com/ (Added: Wed Feb 06 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Parkinson’s disease treatment market - Recent developments: Parkinson's ailment is a dynamic, degenerative neurological engine issue, essentially influencing the dopaminergic cells of the mind. The manifestations of this sickness incorporate unbending nature, tremor, bradykinesia, and postural insecurity. Network Research and Development Information Service is utilizing CDNF, which is a protein, with the goal that the body won't transport it to the mind if it's taken as a pill or an infusion. In this examination, the investigational treatment is being regulated straightforwardly into the mind utilizing an embedded medication conveyance framework suited for Parkinson's patients. Rising seniority populace and higher occurrences of neurodegenerative sicknesses are two huge components that drive the development of this market. Besides, expanding R&D speculation and the number of medications in the pipeline is additionally expected to fuel the market development. To know more, read @https://www.marketdataforecast.com/market-reports/parkinsons-disease-market-7378/ Market segmentation: Drug Class: • Dopamine Receptor Antagonists • Mono Amine Oxidase Inhibitors • Carbidopa • Anticholinergics Distribution Channel: • Retailer Pharmacies • Hospital Pharmacies • Online Pharmacies Patient Care Setting: • Clinics • Hospitals The huge offer of this section can essentially be credited to the accessibility of a wide scope of medications in these offices and the expanding number of patient visits to emergency clinics. Geographical segmentation: North America: • The U.S. Europe: • UK • France • Germany Asia Pacific: • China • Japan • India Latin America: • Brazil The Middle East and Africa: • Europe is foreseen to accomplish the biggest offer of the worldwide Parkinson's sickness treatment showcase, which is probably going to be trailed by North America with a significant piece of the pie. Key Market Players: • Teva (Israel) • Novartis AG (Switzerland) • GSK (UK) • AbbVie (US) • Merck (US) • Boehringer Ingelheim (Germany) • Impax Laboratories (US) • Lundbeck (Denmark) • Sun Pharma (India) • Wockhardt (India) • UCB (Belgium) • Valeant Pharmaceuticals (Canada) • Acadia (US) View a sample and decide @https://www.marketdataforecast.com/market-reports/parkinsons-disease-market-7378/request-sample The Scope of the Report: The report fuses top to bottom evaluation of the focused scene, item advertises measuring, item benchmarking, showcase patterns, item advancements, money related investigation, key examination, etc. to check the effect powers and potential chances of the market. Aside from the syndicated report, our skilled employees have mastery in structuring custom reports to meet your particular research needs and help you in making all around educated choices. About Us: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. For more information: Abhishek Shukla Sales Manager at Market Data Forecast Email: abhishek@marketdataforecast.com Tel: +1-888-702-9626 Website: https://www.marketdataforecast.com/ (Added: Wed Feb 06 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Artificial Bone Market to Reflect Steady Growth During 2018 – 2026 - Inorganic non-metallic materials such as Hydroxyapatite (HA) are increasingly being used for artificial bone applications, owing to its good biocompatibility in bone contact, as its chemical composition is similar to that of bone material. A study published in Artificial Cells, Nanomedicine, and Biotechnology Journal in March 2014, highlighted the clinical effectiveness of nano-hydroxyapatite (Nano-HA) artificial bone. The study shows that, 27 patients suffering with bone defects are treated with Nano-HA artificial bone. After, the continuous follow-up for around 18.5 months, patients’ defected bone shows good biocompatibility with Nano-HA artificial bone, without and side effects and complication. Moreover, increasing adaptation of innovative material in the manufacturing of artificial bone, will expected to boost the market. HA is the main inorganic component of nature bones, accounting for about 60% of the bone composition. Porous HA ceramics have remarkable usage in biomedical applications, including bone tissue regeneration, cell proliferation, and drug delivery. In bone tissue engineering, it is applied as a filling material for bone defects and augmentation, artificial bone graft material, and prosthesis revision surgery. Moreover, significant research is being conducted to use innovative biomaterials such as carbon nanomaterials in bone tissue engineering. Carbon-based prostheses are promising materials, which mimic the natural function of bones, offering relevant mechanical strength. A variety of synthetic polymers, natural polymers, and bioceramics are being used to develop artificial bones and are being investigated for their physiochemical role in vivo, which are currently in clinical trial stages. Furthermore, carbon-based bone materials, such as carbon nanotubes and graphene, have been widely investigated as potential solutions to several biomedical problems. Electrical and mechanical properties of carbon nanotubes (CNTs) are important key properties, which can used for bone tissue engineering. Among this, electrical properties of carbon nanotubes used to stimulate the cell towards osteogenic differentiation, and mechanical properties can be used to mimic the mechanical strength of the bone. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1899 Artificial Bone Market – Drivers Increasing technological development in artificial bones is currently driven with 3-D printing design. The new 3-D printing design is a relatively safer and effective technology in the manufacturing of artificial bones. Various research organizations are engaged in carrying out extensive research and development in 3-D artificial bone design profiling. For instance, according to the data published in ScienceDaily Journal, in August 2017, researchers from University of British Columbia, Canada, developed a new artificial bone design that can be customized and made with a 3-D printer for stronger, safer, and highly effective bone replacements. Rising incidence of trauma and accidents across the globe, in turn, is increasing the prevalence of bone damage, which is thus expected to boosting the growth of the artificial bone market. For instance, according to the Centers for Disease Control and Prevention (CDC), around 2.5 million people were hospitalized in the U.S. in 2014, due to accident injuries, indicating high risk of bone damage. This in turn, offers lucrative opportunity to boost artificial bone market over the forecast period (2018 – 2026). Moreover, the National Trauma Institute in 2014, revealed that economic burden due to trauma cases increased to US$ 671 billion, including healthcare costs and lost productivity costs. Increasing number of trauma cases is increasing the visits of patients in trauma centres. According to the National Ambulatory Medical Care Survey (NAMCS), in 2010, around 63 million visits to the orthopedic surgery department were recorded and around 3.5 million visits for fractures in the emergency departments in the U.S. Additionally, among the 6.5 million bone fracture or defect cases, around 887,679 were hospitalized. Various other factors such as presence of key operating players and collaborative partnerships among the players are responsible for positioning North America as the largest market for artificial bone market. Artificial Bone Market – Regional Analysis Geographically, the global artificial bone market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds the dominant position in the artificial bone market. North America contributes the maximum share in the artificial bone market and is expected to generate high revenue during the forecast period, owing to increasing research and development activities in the field of artificial bone, which results in development of innovative artificial bone manufacturing technologies in the region. On the other hand, Asia Pacific is expected to gain significant traction, owing to the rise in medical tourism as well as development of novel artificial bone material by regional players, exhibiting equivalent efficiency at affordable prices. For instance, in September 2016, a medical 3D printing alliance, which consisting of Taiwan’s National Applied Research Laboratories (NARLabs), China Steel’s branch company ThinTech Materials Technology, the TongTai Group, and the United Orthopedic Corporation; launched new medical 3D printing bone material. This new material underwent and passed the ISO-10993 biocompatibility international regulation’s verification. The group is intended to launch its new material in the global market over the forecast period. Artificial Bone Market – Competitor Some of the key players operating in the artificial bone market are Baxter International Inc., Medtronic plc, Stryker Corporation, Orthofix International N.V., AlloSource, Inc., Johnson & Johnson (DePuy Synthes), NuVasive, Inc., and Smith & Nephew plc. Click To Reading More On Artificial Bone Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. (Added: Wed Feb 06 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Clinical Decision Support System Market, Size, Share, Growth, Analysis and Forecast 2024 - Industry Overview The global clinical decision support system market is predicted to grow at 13.6% CAGR during the forecast period with the market size reaching USD 2.0 billion by 2024. Different types of products such as integrated and standalone are majorly contributing to the clinical decision support system market size. The market has witnessed significant demand for integrated over the last few years due to escalating implementations of integrated CDSS. Market Segmentation 1) Insight by Component This segment is divided into innumerable subdivision. However, following are the major dominant ones: • Software • Hardware • Services Software hold the largest share in the clinical decision support system market, globally. Repeated characteristic of services such as consulting, installation, training and development, software upgrades, and maintenance led to the fastest growth of the services segment during the historical period, which is also predicted to continue during the forecast period. 2) Insight by Type The market can be segmented into two types: • Conventional • Advanced Of all, the advanced category is predicted to witness the higher CAGR during the forecast period due to healthcare organizations endeavoring to upgrade CDSS systems which execute functions such as protocol validation, population health management, health economics management, and treatment planning. 3) Insight by Product On the basis of product, the market is divided into two types: • Integrated • Standalone Of all, the integrated category is predicted to witness the higher CAGR during the forecast period. 4) Insight by Model On the basis of model, the market is divided into two types: • Knowledge-Based • Non-Knowledge Based Of all models, knowledge-based category accounted the larger share and predicted to witness the higher growth during the forecast period in the clinical decision support system market, due to various advantageous functionalities, such as helping clinicians to make clinical decisions in the case of doubts. 5) Insight by Delivery Mode On the basis of delivery mode, the market is divided into three types: • Web-Based • Cloud-Based • On-Premise Of all, the clinical decision support system market size for cloud-based is expected to grow at the fastest rate during the forecast period, globally, due to its affordability, scalability, and affordability, and the lower capital expenses and operational costs. 6) Insight by Application This segment is divided into innumerable subdivision. However, following are the major dominant ones: • Drug Dosing Support • Drug Allergy Alert • Drug-Drug Interaction • Clinical Reminder • Clinical Guideline • Others Of all, the clinical decision support system market size for a clinical reminder is expected to grow at the fastest rate during the forecast period, globally. Industry Dynamics 1) Growth Drivers Factors that have been acting as the driving factors for the growth of this industry are: i. The mounting occurrence of chronic diseases ii. Budding implementation of cloud computing in healthcare iii. Expanding the geriatric population iv. Escalating government support and initiatives v. The mounting occurrence of medication errors vi. High returns on investment for CDSS solutions 2) Challenges The major challenges faced by the key players in this industry are: i. Data security issues ii. Disinclination to accept mobile CDSS iii. Huge investment for information technology infrastructure iv. Lack of interoperability Geographic Overview • Asia Pacific — Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific • North America — US, Canada, and Mexico • Europe — UK, Germany, France, Italy, Spain, Russia, and Rest of Europe • Rest of the World – Brazil, South Africa, Saudi Arabia, U.A.E., and Others Geographically, North America is the largest clinical decision support system market as the region occurrence of medication errors is increasing, and the mounting requirement for quality healthcare delivery. In addition, regulatory mandates, escalating healthcare IT expenditure, technological advancements in healthcare IT solutions, and mounting occurrence of chronic diseases are also fueling the growth of the North American clinical decision support system market. Competitive Insight The Key players in the global clinical decision support system market are Wolters Kluwer Health, Cerner Corporation, Philips Healthcare, IBM Corporation, Hearst Health, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Mckesson Corporation, and MEDITECH. (Added: Wed Feb 06 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Clinical Decision Support System Market, Size, Share, Growth, Analysis and Forecast 2024 - Industry Overview The global clinical decision support system market is predicted to grow at 13.6% CAGR during the forecast period with the market size reaching USD 2.0 billion by 2024. Different types of products such as integrated and standalone are majorly contributing to the clinical decision support system market size. The market has witnessed significant demand for integrated over the last few years due to escalating implementations of integrated CDSS. Market Segmentation 1) Insight by Component This segment is divided into innumerable subdivision. However, following are the major dominant ones: • Software • Hardware • Services Software hold the largest share in the clinical decision support system market, globally. Repeated characteristic of services such as consulting, installation, training and development, software upgrades, and maintenance led to the fastest growth of the services segment during the historical period, which is also predicted to continue during the forecast period. 2) Insight by Type The market can be segmented into two types: • Conventional • Advanced Of all, the advanced category is predicted to witness the higher CAGR during the forecast period due to healthcare organizations endeavoring to upgrade CDSS systems which execute functions such as protocol validation, population health management, health economics management, and treatment planning. 3) Insight by Product On the basis of product, the market is divided into two types: • Integrated • Standalone Of all, the integrated category is predicted to witness the higher CAGR during the forecast period. 4) Insight by Model On the basis of model, the market is divided into two types: • Knowledge-Based • Non-Knowledge Based Of all models, knowledge-based category accounted the larger share and predicted to witness the higher growth during the forecast period in the clinical decision support system market, due to various advantageous functionalities, such as helping clinicians to make clinical decisions in the case of doubts. 5) Insight by Delivery Mode On the basis of delivery mode, the market is divided into three types: • Web-Based • Cloud-Based • On-Premise Of all, the clinical decision support system market size for cloud-based is expected to grow at the fastest rate during the forecast period, globally, due to its affordability, scalability, and affordability, and the lower capital expenses and operational costs. 6) Insight by Application This segment is divided into innumerable subdivision. However, following are the major dominant ones: • Drug Dosing Support • Drug Allergy Alert • Drug-Drug Interaction • Clinical Reminder • Clinical Guideline • Others Of all, the clinical decision support system market size for a clinical reminder is expected to grow at the fastest rate during the forecast period, globally. Industry Dynamics 1) Growth Drivers Factors that have been acting as the driving factors for the growth of this industry are: i. The mounting occurrence of chronic diseases ii. Budding implementation of cloud computing in healthcare iii. Expanding the geriatric population iv. Escalating government support and initiatives v. The mounting occurrence of medication errors vi. High returns on investment for CDSS solutions 2) Challenges The major challenges faced by the key players in this industry are: i. Data security issues ii. Disinclination to accept mobile CDSS iii. Huge investment for information technology infrastructure iv. Lack of interoperability Geographic Overview • Asia Pacific — Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific • North America — US, Canada, and Mexico • Europe — UK, Germany, France, Italy, Spain, Russia, and Rest of Europe • Rest of the World – Brazil, South Africa, Saudi Arabia, U.A.E., and Others Geographically, North America is the largest clinical decision support system market as the region occurrence of medication errors is increasing, and the mounting requirement for quality healthcare delivery. In addition, regulatory mandates, escalating healthcare IT expenditure, technological advancements in healthcare IT solutions, and mounting occurrence of chronic diseases are also fueling the growth of the North American clinical decision support system market. Competitive Insight The Key players in the global clinical decision support system market are Wolters Kluwer Health, Cerner Corporation, Philips Healthcare, IBM Corporation, Hearst Health, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Mckesson Corporation, and MEDITECH. (Added: Wed Feb 06 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Clinical Decision Support System Market, Size, Share, Growth, Analysis and Forecast 2024 - Industry Overview The global clinical decision support system market is predicted to grow at 13.6% CAGR during the forecast period with the market size reaching USD 2.0 billion by 2024. Different types of products such as integrated and standalone are majorly contributing to the clinical decision support system market size. The market has witnessed significant demand for integrated over the last few years due to escalating implementations of integrated CDSS. Market Segmentation 1) Insight by Component This segment is divided into innumerable subdivision. However, following are the major dominant ones: • Software • Hardware • Services Software hold the largest share in the clinical decision support system market, globally. Repeated characteristic of services such as consulting, installation, training and development, software upgrades, and maintenance led to the fastest growth of the services segment during the historical period, which is also predicted to continue during the forecast period. 2) Insight by Type The market can be segmented into two types: • Conventional • Advanced Of all, the advanced category is predicted to witness the higher CAGR during the forecast period due to healthcare organizations endeavoring to upgrade CDSS systems which execute functions such as protocol validation, population health management, health economics management, and treatment planning. 3) Insight by Product On the basis of product, the market is divided into two types: • Integrated • Standalone Of all, the integrated category is predicted to witness the higher CAGR during the forecast period. 4) Insight by Model On the basis of model, the market is divided into two types: • Knowledge-Based • Non-Knowledge Based Of all models, knowledge-based category accounted the larger share and predicted to witness the higher growth during the forecast period in the clinical decision support system market, due to various advantageous functionalities, such as helping clinicians to make clinical decisions in the case of doubts. 5) Insight by Delivery Mode On the basis of delivery mode, the market is divided into three types: • Web-Based • Cloud-Based • On-Premise Of all, the clinical decision support system market size for cloud-based is expected to grow at the fastest rate during the forecast period, globally, due to its affordability, scalability, and affordability, and the lower capital expenses and operational costs. 6) Insight by Application This segment is divided into innumerable subdivision. However, following are the major dominant ones: • Drug Dosing Support • Drug Allergy Alert • Drug-Drug Interaction • Clinical Reminder • Clinical Guideline • Others Of all, the clinical decision support system market size for a clinical reminder is expected to grow at the fastest rate during the forecast period, globally. Industry Dynamics 1) Growth Drivers Factors that have been acting as the driving factors for the growth of this industry are: i. The mounting occurrence of chronic diseases ii. Budding implementation of cloud computing in healthcare iii. Expanding the geriatric population iv. Escalating government support and initiatives v. The mounting occurrence of medication errors vi. High returns on investment for CDSS solutions 2) Challenges The major challenges faced by the key players in this industry are: i. Data security issues ii. Disinclination to accept mobile CDSS iii. Huge investment for information technology infrastructure iv. Lack of interoperability Geographic Overview • Asia Pacific — Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific • North America — US, Canada, and Mexico • Europe — UK, Germany, France, Italy, Spain, Russia, and Rest of Europe • Rest of the World – Brazil, South Africa, Saudi Arabia, U.A.E., and Others Geographically, North America is the largest clinical decision support system market as the region occurrence of medication errors is increasing, and the mounting requirement for quality healthcare delivery. In addition, regulatory mandates, escalating healthcare IT expenditure, technological advancements in healthcare IT solutions, and mounting occurrence of chronic diseases are also fueling the growth of the North American clinical decision support system market. Competitive Insight The Key players in the global clinical decision support system market are Wolters Kluwer Health, Cerner Corporation, Philips Healthcare, IBM Corporation, Hearst Health, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Mckesson Corporation, and MEDITECH. (Added: Wed Feb 06 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• DNA Polymerase Market Analysis -

  DNA polymerase is class of enzyme present in the organisms. The role of DNA polymerase enzymes is to replicate DNA, thereby helping in DNA repair and maintenance. This enzyme is used to the transfer genetic information from across generations. DNA polymerase works on phenomenon by shifting along with single strand template reading nucleotide bases as it goes. The global DNA polymerase market is expected to reach a value of US$ 389.4. Mn by the end of 2027, according to a latest research by Future Market Insights (FMI). The report on DNA polymerase further projects significant growth potential with average year-on-year growth rate of 6.5% through 2027.

  DNA polymerase enzymes have paved growth path for DNA replication and transcription technique. DNA polymerases play an important role in development of PCR, and sequencing, on which the current biotechnology is standing. Besides, polymerases are the main engine for various molecular biology operations including DNA labelling, amplification and sequencing. DNA polymerases are the basic components used in molecular diagnostics for personalized medicine. DNA polymerases are the building blocks of novel genetic techniques, which are used to detect alterations in genomics that can cause various diseases. Commercialization of new DNA polymerases families is creating new avenue for growth for the DNA polymerase market. The prominent types of DNA polymerases used in biotechnology are labelled under A and B category. These DNA polymerases enzymes are single subunit polymerases. Genetically engineered tailor-made DNA polymerase enzymes would be the next pocket of investment. The promising attributes of these DNA polymerase are likely to increase the accuracy of PCR technique and also enable end users to conduct molecular testing directly from tissue sample. These novel DNA polymerase enzymes also find application in whole genome amplification and in next-generation sequencing technique.

  Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-801 

  The automation of sample handling processes includes automated clinical and analytical testing, high throughput screening, diagnostics and large-scale bio-repositories, which help to ease operator workflow, reduce sample preparation time and avoid errors in dispensing and handling. Increasing use of automation in different end-use segments is expected to fuel the demand for high-throughput techniques, which increases the demand for higher quantity of reagents (DNA Polymerase) used in the process. The growing demand for high-quality reagents is creating the need to launch novel products in the market. Qiagen offers the QIAgility system for rapid, high-precision PCR setup, and Tecan also offers multiple solutions for automated PCR setup. Several manufacturers are also remolding their product offerings to ensure compatibility with automated systems to better integrate with end customer workflows.

  The DNA polymerase market has several large players as well as multiple smaller companies. There are limited companies that have a complete focus on being a provider of reagents for research and diagnostic use. Different vendors have different specializations and product offerings, with most of the large companies combining research products and reagents with equipment, in-vitro diagnostics tools, etc. Having a sole focus on DNA polymerase market ensures better quality of products, customer loyalty and an established distribution network that can cater to product availability around the globe. R&D spending on life sciences and investment in developing molecular diagnostics kits and reagents are expected to grow at a stable rate over the next several years.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-801

  FMI has segmented the global DNA polymerase market into product type, end users, & regions. In terms of revenue, the eukaryotic DNA polymerase segment holds substantial market share and is expected to gain traction due to increased demand for DNA polymerase and its consequent adoption over the forecast period. The segment in DNA polymerase market is expected to exhibit healthy CAGR of 6.7% over the forecast period.

  The report covers some of the key companies operating in the DNA polymerase market, which include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., Agilent Technologies Inc., Takara Bio Inc., Genescript, Illumina Inc., New England Biolabs, Inc., and Bioline & Promega Corporation, among others

  (Added: Wed Feb 06 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• RAS Luxury Oils launches Valentine’s Edition Gift Box - Pamper yourself and your loved ones on this special day, with the gift of RAS. New Delhi, 06th February 2019: RAS Luxury Oils, a ‘Farm-to-Bottle’ homegrown skincare, and wellness brand has launched its Valentine’s Day Special gift boxes, made with the purest, 100% natural and organic, plant-based ingredients that are chemical and preservatives free. These products, manufactured at their own farms or fairly sourced directly from farmers, cater to all skin types. This limited edition Valentine’s Day gift box, available for the entire month of February, is meant for ‘Relaxation and Pampering’, includes a Radiance Beauty Boosting Day Face Elixir that nourishes and enriches the skin by detoxing and enhancing the skin from within, toning it effectively and clearing blemishes and dark spots. Rose Nectar Face Spritz with Geranium and Lavender oil is a hydrating concoction that revitalizes skin to leave it with a timeless glimmer that lasts. Bliss Liquid Luxury has a harmonizing effect on the body and mind, and Kashmiri Lavender Pure Essential Oil calms the mind, heals wounds, reduces scarring and gives a feeling of deep relaxation. Miss Shubhika Jain, Founder & CEO, RAS Luxury Oils said, “This Valentine’s Day Special Gift Box, both for men and women, includes products that are infused with quality natural ingredients. We feel that our organic and handcrafted gift hampers will bring out the natural glow and elevate the radiant inner beauty which makes them a must-have product for gifting your loved ones (or even pampering yourself) on this Valentine’s Day”. Winner of the Asia Spa Awards 2017 for the Best Spa Product- Natural Line, RAS products are PETA Certified cruelty-free and vegan, made with only 100% natural botanicals for the wellness of mind, body, and soul. Hampers are available at a price of Rs. 7190 online on www.rasluxuryoils.com. About RAS Luxury Oils RAS Luxury Oils, is India’s first ‘Farm to Bottle’ venture, striving to introduce 100% pure, honest and absolutely luxurious beauty and skincare products. The brand encourages people around the globe to say NO to unnatural, unpronounceable ingredients. The company has vertically integrated processes from cultivation in its own farms in Raipur to oil extraction, along with formulation at its own DSIR-approved R&D lab in Raipur. For further information please visit www.rasluxuryoils.com. (Added: Wed Feb 06 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• RAS Luxury Oils launches Valentine’s Edition Gift Box - Pamper yourself and your loved ones on this special day, with the gift of RAS. New Delhi, 06th February 2019: RAS Luxury Oils, a ‘Farm-to-Bottle’ homegrown skincare, and wellness brand has launched its Valentine’s Day Special gift boxes, made with the purest, 100% natural and organic, plant-based ingredients that are chemical and preservatives free. These products, manufactured at their own farms or fairly sourced directly from farmers, cater to all skin types. This limited edition Valentine’s Day gift box, available for the entire month of February, is meant for ‘Relaxation and Pampering’, includes a Radiance Beauty Boosting Day Face Elixir that nourishes and enriches the skin by detoxing and enhancing the skin from within, toning it effectively and clearing blemishes and dark spots. Rose Nectar Face Spritz with Geranium and Lavender oil is a hydrating concoction that revitalizes skin to leave it with a timeless glimmer that lasts. Bliss Liquid Luxury has a harmonizing effect on the body and mind, and Kashmiri Lavender Pure Essential Oil calms the mind, heals wounds, reduces scarring and gives a feeling of deep relaxation. Miss Shubhika Jain, Founder & CEO, RAS Luxury Oils said, “This Valentine’s Day Special Gift Box, both for men and women, includes products that are infused with quality natural ingredients. We feel that our organic and handcrafted gift hampers will bring out the natural glow and elevate the radiant inner beauty which makes them a must-have product for gifting your loved ones (or even pampering yourself) on this Valentine’s Day”. Winner of the Asia Spa Awards 2017 for the Best Spa Product- Natural Line, RAS products are PETA Certified cruelty-free and vegan, made with only 100% natural botanicals for the wellness of mind, body, and soul. Hampers are available at a price of Rs. 7190 online on www.rasluxuryoils.com. About RAS Luxury Oils RAS Luxury Oils, is India’s first ‘Farm to Bottle’ venture, striving to introduce 100% pure, honest and absolutely luxurious beauty and skincare products. The brand encourages people around the globe to say NO to unnatural, unpronounceable ingredients. The company has vertically integrated processes from cultivation in its own farms in Raipur to oil extraction, along with formulation at its own DSIR-approved R&D lab in Raipur. For further information please visit www.rasluxuryoils.com. (Added: Wed Feb 06 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Molecular Imaging Market 2017 -

  The global molecular imaging market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing demand for advanced integrated molecular imaging devices such as PET-CT and PET-MR from hospitals and diagnostics imaging centres. “Molecular Imaging Market: Global Industry Analysis (2012 –2016) and Opportunity Assessment (2017 – 2027),” is the newly published report by Future Market Insights which focuses on the key strategies such as acquisitions, mergers, expansion and product launchesadopted by the manufacturers and integrators in this market for technology transfer and to increase consumer base in different geographies. The global molecular imaging market is projected to register a CAGR of 7.5% in terms of value during the forecast period i.e. 2017–2027 and to be valued at US$ 6,445.8 Mn by 2027.

  Global Molecular Imaging Market: Drivers

  Following are some of the factors which are contributing in the growth of the global molecular imaging market throughout the forecasted period.

  • Advancements in the molecular imaging

  • Favorable reimbursement for molecular imaging and treatment

  • Increasing demand for molecular imaging and diagnosis

  • Increasing incidences of ageing population’s MRI diagnostics

  • Expanding application of integrated PET-CT and PET-MR devices

  • Favorable government policies for startup companies

  • Increasing Strategic Collaborations among key players

  • Increasing reliance of physicians and radiologists on the technology

  Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-724

  Global Molecular Imaging Market: Forecast by Modality Type

  On the basis of modality type, the global molecular imaging market is segmented into- Positron Emission Tomography (PET), Positron Emission Tomography- Computed Tomography (PET-CT),

  Positron Emission Tomography-Magnetic Resonance (PET-MR), Single Photon Emission, Computed Tomography (SPECT), Magnetic Resonance Spectroscopy, Molecular Ultrasound Imaging Software. The SPECT segment of modality type accounted for 23.3%market share in 2016, which is expected to decrease to 22.7% by 2027end. This segment is expected to accounts for large revenue contributionto the global molecular imaging market as compared to other segmentsover the forecast period. On the other hand PET-CT molecular imaging segment is expected to witness a significant rise in revenue share over the forecast period, owing to increasing awareness about the advantages of PET-CT integrated devices compared to stand alone molecular imaging devices.

  Global Molecular Imaging Market: Forecast by End User

  This segment consists of hospital, ambulatory surgical centre, and diagnostic imaging centre. Hospital segment is sub-segmented into 500 + beds, 200-499 beds, and less than 200 Beds. Hospital segment dominated the global molecular imaging market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Hospitals segment is expected to be the most lucrative among all end users, with attractiveness index of 1.8. This segment is expected to grab 58% revenue share in 2027.

  Global Molecular Imaging Market: Forecast by Application

  Application segment includes cardiology, oncology, gastrointestinal disorders, neurology disordersand others. In terms of value, oncology is the largest segment and is likely to be valued US$ 2,391.7 Mn in 2027. However, in terms of CAGR, neurological disorders segment is ahead with 8.4% Compound Annual Growth Rate at the end of the projected period. By market share index, this segment is expected to be the second largest in the global molecular imaging market.

  Global Molecular Imaging Market: Forecast by Region

  This report has covered seven regions such as North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan, and MEA. APEJrepresents the most lucrative market, followed by MEA andNorth America. The APEJ molecular imaging market revenue is expected to expand at a significant CAGR of 8.6% in terms of value over the forecast period. The hospitals and diagnostics imaging centres in APEJ are expectedto witness comparatively significant growthdue to increasingdemand of advanced molecular imaging and developing medicalinfrastructure in the region.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-724

  Global Molecular Imaging Market: Key Players

  These are some of the key players in the global molecular imaging market- Hermes Medical Solutions, MIM Software Inc., Bruker Corporation, GE Company, Fujifilm Holdings Corp., Siemens AG, Koninklijke Philips N.V., Toshiba Medical System Corp., Hitachi Medical Corp.,Medisco Ltd., Positron Corporation, Esaote SpA, Carestream Health, Inc., Mirada Medical Limited.

  (Added: Wed Feb 06 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Spinal Muscular Atrophy Market to Exhibit Steadfast Expansion During 2018-2026 - The global spinal muscular atrophy market size was valued at US$ 884 million in 2017 and is expected to witness a robust CAGR of 12.4% over the forecast period (2018–2026). Spinal muscular atrophy (SMA) is a genetic disorder that affects the control of muscle movement. It is caused due to loss of specialized nerve cells, called motor neurons, in the spinal cord and brainstem. The loss of motor neurons leads to weakness and atrophy of muscles used for activities such as sitting up, walking, crawling, and controlling head movement. In severe cases, the muscles used for swallowing and breathing are also affected. There are four types of spinal muscular atrophy, which are differentiated based on the severity of muscle weakness, pattern of features, and age, when the muscle problems begin. These are classified as type 1, 2, and 3 that appears in childhood. Type 4 appears in adulthood and is also termed as adult onset SMA. Various government and private organizations are investing huge capital and resources towards the development of new and effective therapies for spinal muscular atrophy. For instance, in 2015, the SMA Foundation financed over US$ 60 Mn in drug development programs and essential drug discovery assets that aim to develop an effective SMA therapy. In 2013, Cure SMA granted fund to Cytokinetics for the study of Tirasemtiv for SMA. Financial details of the grant were not disclosed. Tirasemtiv is a novel skeletal muscle activator and a lead drug candidate from Cytokinetics' skeletal muscle contractility program. It has been studied in clinical trials for individuals with amyotrophic lateral sclerosis (ALS). Similar to SMA, ALS also affects motor neurons. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1920 The National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), conducts clinical, translational, and basic research on SMA and also supports research through grants to major medical institutions across the U.S. In 2011, the authority established NeuroNext clinical trials network to promote rapid development and implementation of trials for neurological disorders that affect adults and/or children. The network is designed to develop early-phase trials aimed at identifying biomarkers that can be measured to determine the presence and severity of a disease—and testing promising, emerging therapies. Spinal muscular atrophy mainly manifests early in life and therefore is a major genetic cause of death in infants. It is one of the most common rare diseases. According to SMA Foundation 2015 statistics, spinal muscular atrophy has generally been believed to affect as many as 10,000 to 25,000 adults and children in the U.S. In March 2018, CureSMA stated that SMA affects around 1 in 11,000 children, and 1 in 50 is a carrier of the disease. It has been found in people of every race, however, is most common in Caucasians, of whom 1 in 35 is a carrier. Spinal muscular atrophy carrier rates for other populations include Asians (1 in 53), African Americans (1 in 66), and Hispanics (1 in 117). However, high cost of therapy can confine growth of the spinal muscular atrophy market during the forecast period. For instance, Biogen’s Spinraza (nusinersen) drug for spinal muscular atrophy is estimated to cost US$ 125,000 per injection, accounting for US$ 750,000 for the first year and US$ 375,000 later. Click To Reading More On Spinal Muscular Atrophy Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. (Added: Wed Feb 06 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• bionx.es - Bionx.es, blog de actualidad sobre tendencias esteticas. Amplia informacion y novedades sobre todo lo referente a la belleza, tratamientos esteticos, productos cosmeticos naturales, etc. (Added: Wed Feb 06 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Rebel Herbs to Participate in Integrative Healthcare Symposium - Bloomington, IN: (February 5, 2019) From February 21-23, Rebel Herbs will be exhibiting at booth #406 during the Integrative Healthcare Symposium (IHS). The annual conference is the only event in North America where practitioners from a wide array of disciplines join together as a unified community. Each year, attendees assemble to learn, connect, collaborate, and incorporate new techniques and insights into their practices. This year, distinguished speakers will discuss a variety of topics, including the evolution of nutrition science, the connection between genes and diseases, and research in the use of cannabis as a part of cancer care. Tena Edwards, COO of Rebel Herbs, stated that she is, “enthusiastically anticipating meeting and connecting with the attendees, and exhibiting the innovative products and services that our company has to offer”. Rebel Herbs is a brand of unique organic herbal products; including supplements, powders and vapors which are made exclusively from plants grown and harvested at the company’s certified organic farms. The company’s mission is to bring Ayurveda, an ancient healing practice hailing from India, to the global market by means of easier accessibility while ensuring quality and ethical responsibility for all parties involved. The company’s operation is sustainable. Adhering to its resolve for economical and ethical accountability, it has educated local farmers on organic farming and other viable practices. The company funds local farmers’ certification and contracts them to grow and supply herbs and spices. The company looks to build a long term revenue engine for everyone in its chain of supply. The company has established that its workers are paid 20% more than the average wage for their positions. This has helped over 400 employees living in India provide a better life for their families. Furthermore, this method provides the crucial processes that the company has for full control of its product from soil to shelf, in addition to minimizing environmental impact. Rebel Herbs manufactures and distributes botanical products around the world and is headquartered in Indiana, USA. (Added: Tue Feb 05 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Protein Sequencing Market Outlook to 2026 Reported in Latest Research - Protein sequencing is a popular de novo sequencing method for the determination and analysis of the amino acid sequence from the mass spectrum. The process enables researchers obtain information about protein conformation. Protein sequencing has established itself as high-throughput proteomic technique and have several applications. One of the prominent applications is in target-based drug discovery. A range of various computational methods and experimental methods, notably Edman degradation and Mass Spectrometry, are used for protein sequencing. Several biotechnology and pharmaceutical companies are making sizeable investments on utilizing protein sequencing in drug development. Read Report Overview: https://www.transparencymarketresearch.com/protein-sequencing-market.html Protein sequencing are extensively used in protein engineering studies and for identifying new protein biomarkers. The technique has also gained some traction in cDNA library screening. Growing role of biotherapeutics and genetic engineering is expected to underpin the evolution of the protein sequencing market. The report offers critical assessment of key growth dynamics and emerging application avenues in various regions. The study presents elaborate and evidence-driven insights on technology advancements and key end-user trends. Increasing focus on target-based drug development activities by biotechnology and pharmaceutical companies in various developing and developed regions is a key factor driving the market. Recent advances in de novo peptide-sequencing methods and analytical methods, with the application of neural networks, have opened new avenues in the market. Technological advances in mass spectrometer is a case in point. Rising funding on proteomics research in numerous developing and developed nations is a key factor boosting the market. The rising demand for protein biomarkers in drug development process is a key trend fueling the rapid expansion of the protein sequencing market. However, the uptake of protein sequencing method is constrained by the high cost of infrastructures and equipment, such as that of mass spectrometers. The growing application of protein sequencing technique for identifying novel peptides in human antibodies and antigens is also boosting the market. Furthermore, the paucity of adequate technological expertise and laboratory infrastructures in some parts of the world are factors that hinder the market to realize its full potential. Nevertheless, technological advancements for the identification of isobaric residues in protein sequences are expected to unlock vast potential prospect in the global protein sequencing market. Of all the regions, North America holds an enormous potential in the protein sequencing market. Substantial size in regional revenues over the assessment period is driven by burgeoning research and development expenditure of prominent pharmaceutical and biotechnology companies. In addition, several public and private organizations have committed large funds on proteomic research. Rising focus of players on structure-based drug design and the advent of technologically-advanced analytical methods used in protein sequencing are bolstering the regional demand. Several top players are aimed at launching cutting-edge mass spectrometry platforms to gain unique competitive edge over their peers in the global protein sequencing market. Some prominent companies are also consolidating their overall presence by strengthening the sales of reagents and consumables. Top players operating in the market include Thermo Fisher Scientific, Bioinformatics Solutions, Charles River Laboratories, SGS S.A., and Shimadzu Corp. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Feb 05 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Ophthalmology PACS Market Explores New Growth Opportunities by Leading Manufacturers - One of the integral part of ophthalmic division is ophthalmic imaging. It permits the clinician to keep an observation on the findings through clinical ocular examination in an objective, transmissible, reproducible, and durable manner. Ophthalmic imaging devices enable the identification of diseases and anatomical features which are not easily seen through standard examination techniques, and facilitate quantitative analysis. Ophthalmic imaging is used for diagnosis, treatment, and long-term monitoring of ocular conditions. It also plays a vital role in screening of ophthalmic diseases, clinical trials, teaching, telemedicine, and virtual clinics. Instrument suppliers provide a software which includes a patient database that can be connected to the server and the data folder will be placed on a storage device. Due to the advancements in software, more detailed statistics are captured by the software, leading to increase in the volume of per patient data captured. This data is then stored in the software, accessible to the doctor as and when he needs to retrieve it. Read Report Overview: https://www.transparencymarketresearch.com/ophthalmology-pacs-market.html The PACS system ensures connectivity between multiple modalities, enabling the clinician to receive data from different modalities in a single report. PACS enables the end-user to have all data of the patient from a single system and speed up patient input by machine, thereby promoting a paperless environment. PACS is a lightweight system. There is a significant amount of informal and non-billable, important communication that is facilitated by PACS. Demand for PACS systems is expected to grow rapidly as digital cameras and other image devices are becoming more frequent in health care. This enables clinicians to learn to communicate with images. PACS has innovative uses and strong clinical evidences which is expected to aid in building its user community. Rise in adoption of teleophthalmology across the world is likely to drive the global ophthalmology PACS market during the forecast period. However, regular maintenance of the system, implementation, and initial acquisition of the system are anticipated to restrict the growth of the ophthalmology PACS market in the near future as these involve additional and recurring costs. Digital acquisition devices, communications networks, and mass storage devices and related software are included in acquisition costs. Then comes implementation cost which involves integration and the training of personnel on PACS. The global ophthalmology PACS market can be segmented based on type, delivery model, and end-user. Based on type, the ophthalmology PACS market can be divided into standalone PACS and integrated PACS. The integrated PACS segment is projected account for the dominant share of the ophthalmology PACS market during the forecast period. Integrated PACS system offers several advantages, such as, easy deployment and use, data security, easy interoperability, cost-effectiveness, and portability. These factors are expected to boost the growth of the segment in the near future. In terms of delivery model, the global ophthalmology PACS market can be classified into Web or cloud-based model and on-premise model. The on-premise model segment is estimated to lead the ophthalmology PACS market in the next few years as on-premise models permit higher degree of customization than the web or cloud-based models. Based on end-user, the ophthalmology PACS market can be segmented into hospitals, specialty clinics, ambulatory surgery centers, medical education centers, and eye research institutes and laboratories. Hospitals are anticipated to have a leading share in the ophthalmology PACS market during the forecast period, as the trend of hospitals being funded by investments is growing in North America. Geographically, the global ophthalmology PACS market can be distributed into North America, Europe, Latin America, Asia Pacific and Middle East & Africa. North America is expected to account for a substantial share of the global market and is forecasted to lead the market during the forecast period. Growth of the region in the global market can be attributed to the strategic presence of key market players in the U.S. and Canada. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56127 Prominent players operating in the global ophthalmology PACS market include IBM Watson Health, EyePACS, Carl Zeiss Meditec AG, Heidelberg Engineering, Sonomed Escalon, Topcon Corporation, and Visbion. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Feb 05 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Low-cost Global Aviation Air Ambulance Services Now in Ranchi with Advanced Equipment - February 05, 2019 - Global Air Ambulance, Yesterday it came up with great news which is helpful for Ranchi people as well as Delhi people that it is going to provide our both Aircraft for the benefits of the patients. Global Air Ambulance Service is available 24/7 hours into 365 days for the serious and very critical ICU patients in this city to other cities. Global Air Ambulance to transfer your loved ones to the hospital wherever they want to shift them. With the immense experience of patient transfer, we have gained the rank and reputation of being the most trusted Air Ambulance operator in India and even abroad. Things that are provided in Global Air Ambulance The World best Air Ambulance Service Hi-Tech Medical Equipment’s 24/7 Service Well-Experienced MD Doctors and Expert paramedics Hassle- Free Bed to Bed Patient Transfer Global Cost Air Ambulance Service from Ranchi to Delhi includes medications, ventilators, ECGs and monitoring units, CPR equipment, scoop stretchers, and wheelchairs. It has a great team of MD Doctors and best team of paramedical technicians and also Medical Charted Aircraft with all advanced equipment’s. Global world class facilities Best hygiene and surrounding Easy transportation Superb medical and health care Global Air Ambulance Service Cost from Delhi to Chennai is rendering the updated medical instruments in Air Ambulance for proper monitoring process likewise Suction Unit, Ultrasound Scanner, Defibrillators, Cardiac Monitor, Iv Pumps and other special ones too. More@ https://www.globalairambulance.in/ (Added: Tue Feb 05 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Dental Mirror Market Strategies And Key Opportunities - Dental mirror, also known as mouth mirror, is widely used in dentistry to achieve indirect vision by dentists. Indirect vision is essential for certain parts of the mouth where visibility is difficult or impossible. Dental mirrors are used to create light by reflection to aid in the visibility. The head o the mirror is generally round in shape. Commonly used mirror sizes are No. 4 Ø (18 mm) and No. 5 Ø (20 mm). Typical design of a dental mirror consists of a small, cylindrical metal shaft. A metal disk is attached to the end of it to hold the mirror. Dental mirrors are biologically inert and can be autoclaved for sterilization purpose. Reusable mirrors are available in the market which can be sterilized and reused, while disposable dental mirrors are available as well. Read Report Overview: https://www.transparencymarketresearch.com/dental-mirror-market.html Rise in the prevalence of dental disorders due to improper eating habits and poor hygiene practices, availability of trained dentists across the world, and advancement in dental technologies are expected to boost the growth of the dental mirror market during the forecast period. Moreover, support and subsidies provided by the government for efficient medical equipment and favorable insurance reimbursement policies are the other factors expected to augment the growth of the market in the near future. However, high cost of dental procedures and ignorance toward timely dental checkups are anticipated to slowdown the growth of the dental mirror market. The global dental mirror market can be segmented based on product type, type of material used, size, reflecting surface of the mirror, and end-user. In terms of product type, the market can be divided into one-sided dental mirror and double-sided dental mirror. In terms of type of material used, the dental mirror market can be categorized into stainless steel mirror, titanium mirror, aluminum mirror, and plastic mirror. Plastic mirrors are disposable. Based on reflecting surface of the mirror, the dental mirror market can be segmented into flat (plain, regular) surface mirror, concave mirror, and front surface mirror. Flat or plain mirrors are highly preferred owing to their good image quality. Based on end-user, the dental mirror market can be split into hospitals, dental clinics, and others. The dental clinics segment is expected to dominate the global dental mirror market during the forecast period. Based on geography, the global dental mirror market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Major demand for dental mirrors is likely to be generated from the developed regions, such as, North America and Europe, owing to high disposable income, significant health care expenditure, presence of large geriatric patient pool seeking advanced medical care, launch of new products, growing prevalence of dental diseases, and increasing number of dental procedures performed in these regions. The dental mirrors market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to improving health care infrastructure in the emerging economies of the region. Not only hospitals in developing countries are generating high demand for advanced dental equipment, specialty clinics are also mushrooming in these countries as more and more medical practitioners are opting for dentistry and working out of their own facilities. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56157 Key players operating in the dental mirror market include Integra LifeSciences, Medesy Srl, Parkell, Inc., PRODONT-HOLLIGER, Zirc, Asa Dental S.p.A., Supply Clinic, Inc., Addler Engineering Solution, Essential Dental Systems, Inc., and HELMUT ZEPF MEDIZINTECHNIK GMBH. These players are focusing on new product launches and mergers and acquisitions strategies to grow their business. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Feb 05 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Integrative Health Services During And After Your Hospital Stay - Ishaq Bin Omran - Ishaq Bin Omran Medical Center Sheikh Salem Al Qassimi Street Al Qarayen Sharjah Telephone: +971 6 518 0800 Email: info@ibo.ae Ishaq Bin Omran Medical Center has a numerous patients who undergo treatment and surgeries as in-patient or outpatient procedyre. The hospital in Sharjah understands the toll and anxiety it can have on patients, whether the treatment is minor or major. As a result, the hospital provides integrative health services to their patient during and after their hospital stay. “We want to help our patients manage the physical and emotional side effects of surgery”, says Dr. Sajid Burud, Medical Director. “We provide a range of services that include wellness groups, acupuncture, massages, yoga and energy therapies”. Patients can take advantage of these services to recover quicker than they would if they were to have treatment elsewhere. The primary goal of the hospital in Sharjah is to focus on patients, and as a result they have developed a patient-first approach. The patient’s needs are given priority and the team of doctors and nurses understand that patients coming in for treatment, however minor it may be, have concerns about their well-being. The team of doctors make it their priority to ensure patients feel relaxed, comfortable and at ease in the hospital environment. They believe that each patient has a unique story and they are devoted to maintaining the highest standard of care. This enables the hospital in Sharjah to deliver effective and efficient healthcare. Ishaq Bin Omran Medical Center provides an integrated system with a one stop solution all under one roof, for consultation, diagnosis, treatment and aftercare. The team of doctors are deeply committed to their patients overall emotional and physical health. “As much as we perform surgery and offer various treatments for our patients to heal physically, we don’t forget that they also need to heal emotionally, and this is what our integrative health services is all about’, further states Dr. Sajid Burud. About Us The Ishaq Bin Omran Medical Center is a leading healthcare provider in Sharjah, and is one of the most trusted and admired healthcare organisations. We provide personalized and outstanding healthcare services to men and women in a comfortable and relaxed surrounding, making use of the latest technology to deliver accurate and fast treatment. Our team is made up of highly skilled physicians providing our patients with the highest standard of treatment and care. Our priority remains to be our patients and our goal is to deliver healthcare with a personal touch. For more information, visit our website on https://ibo.ae/ (Added: Tue Feb 05 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Annual Congress on Child Care: Mental Health, Psychology and Nursing - Dear Colleagues, It is our pleasure to welcome you all at "Annual Congress on Child Care: Mental Health, Psychology and Nursing" during April 12-13, 2019 at Toronto, Canada. For more information visit: https://child.annualcongress.com/ We look forward to a positive response. Best Regards, Jessica Williams | Program Manager Child Congress 2019 Psychology, Psychiatry, Mental Health and Nursing Events WhatsApp: +1 872 999 5846 P: +1 702 508 5200/5201 (Added: Tue Feb 05 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Nasal Drug Delivery Systems Market Stand Out As The Biggest Contributor To Global Growth 2018-2026 - The global nasal drug delivery systems market size is estimated to be valued at US$ 48.1 billion in 2018 and is expected to witness a CAGR of 6.3% over the forecast period (2018 – 2026). Nasal drug delivery system is an alternative to invasive administrations and provides direct access to systemic circulation. Intranasal drug delivery is common and most preferred route of administration in treatment of allergic and non-allergic rhinitis, pain, acute treatment of migraine, and nasal congestion associated with sinusitis, common cold or rhinitis. Nasal drug delivery are mostly used in case wherein rapid onset of action is required, or to reach the site where other route of administration displays ineffective results. Nasal drug delivery is also preferred route for needle-free vaccination and systemic drug delivery. Liquid nasal preparations can be administered through inhalers, droppers, spray pumps, nebulizers or atomizers. Major advantages of nasal drug delivery is that, the drug circumvents hepatic first-pass metabolism, leading to high bioavailability as compared to drug administered orally. On the other hand, parenteral route of administration is also inconvenient for long term therapeutic treatment. Nasal cavity being highly vascular enhances the drug absorption resulting in rapid onset of action. Moreover, ease of administration coupled with non-invasive method is driving adoption of nasal drug delivery systems, in turn propelling nasal drug delivery systems market growth. However, limitations associated with nasal drug delivery system such as histological toxicity or lesser area of absorption as compared to orally administered drug hinders the nasal drug delivery systems market growth. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1944 The regional nasal drug delivery systems market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. North America nasal drug delivery systems market is estimated to hold dominant position in 2017. The factors attributed to growth of the North America in nasal drug delivery systems market is increasing research and development by local manufacturers to develop new drug device or delivery system combination. For instance, Impel NeuroPharma, Inc., a Seattle-based clinical stage biotechnology company, is engaged in applying its Precision Olfactory Delivery (POD) nasal drug delivery platform for drugs such as levodopa powder, insulin liquid, and olanzapine powder for the treatment of Parkinson’s disease, Alzheimer’s disease and agitation in schizophrenia and bipolar disorder, respectively. However, Asia Pacific nasal drug delivery systems market is expected to witness rapid growth, owing to increasing prevalence of diseases, which are expected to be treated by intranasal route of drug delivery. For instance, according to Journal of Allergy and Clinical Immunology, 2017, the prevalence of asthma in developed cities of Asia Pacific such as Hong Kong, Japan, and Singapore is as high as 12.4%. Key players are targeting high patient pool in this region for further growth, which is not expected in matured markets such as North America and Europe. Click To Reading More On Nasal Drug Delivery Systems Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com (Added: Tue Feb 05 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Dermal Fillers and Botulinum Toxin Market Analysis -

  Celebrity endorsements, the quest to look younger and fitter and focussed consumer targeting all point to a bright future for the Dermal Fillers and Botulinum Toxin Market. Future Market Insights has prepared a report titled ‘Dermal Fillers and Botulinum Toxin Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027’ that is a comprehensive look at the Dermal Fillers and Botulinum Toxin Market for the 10-year forecasted period. The Dermal Fillers and Botulinum Toxin Market is expected to witness a CAGR of 7.2% and be worth approximately US$ 9 Bn by the end of the forecast period.

  Forecast by Region: North America Largest Regional Contributor; APEJ has the Maximum Potential

  North America has the largest share by region in the Dermal Fillers and Botulinum Toxin Market and it is anticipated to retain its commanding position throughout the duration of the study. A market pushing past US$ 5 Bn makes North America an extremely lucrative opportunity for key players in the Dermal Fillers and Botulinum Toxin Market. Although APEJ is just a tenth in size of the North America market, APEJ is poised to record a much higher CAGR of 8.2%, making it a region vital for future growth.

  Forecast by Product Type: Botolinum Toxin Most Attractive Segment in the Dermal Fillers and Botulinum Toxin Market

  The botolinum toxin segment dominates the Dermal Fillers and Botulinum Toxin Market by product type. Patients across the world seem to prefer botulinum toxin type-A to eliminate face wrinkles. However, there are only three manufacturers at present and increasing botolinum toxin manufacturing output could prove to be the game changer in the Dermal Fillers and Botulinum Toxin Market. BTXA injections are gaining maximum traction in the Dermal Fillers and Botulinum Toxin Market because of immediately visible improvements and minimal downtime. The botolinum toxin segment is projected to register a CAGR of 6.4% in terms of value during the forecast period.

  Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-4733 

  Forecast by Application: Wrinkle Reduction to Grow Much Faster than Aesthetic Volume Restoration

  The wrinkle reduction segment is comparatively much smaller than the aesthetic volume restoration segment in the Dermal Fillers and Botulinum Toxin Market. However, it is estimated to record a considerably higher CAGR of 8.1% from 2017-2027. The FDA has given their assent to the use of dermal fillers for the purpose of skin enhancement, smoothening, and wrinkle reduction. This should go a long way in raising the prospects of wrinkle reduction in the Dermal Fillers and Botulinum Toxin Market.

  Dermal Fillers and Botulinum Toxin Market: Competition Dashboard

  The main companies profiled in the Dermal Fillers and Botulinum Toxin Market report are SciVision Biotech Inc., TEOXANE Laboratories, Medy-Tox Inc., Daewoong Pharmaceuticals, Grex Pharma SaS, HUGEL, Speciality European Pharma, Suneva Medical, Anika Therapeutics, Merz Pharma GmbH & Co, Galderma SA, and Allergan plc.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-4733

  Key Takeaways from the Report

  Dermal fillers and botulinum neurotoxin type A products are in great demand for wrinkle reduction procedures in monotherapy. The American Academy of Facial Plastic and Reconstructive Surgery states that more than 4/5^th of all surgeons reported a celebrity being the key reason that patients underwent a specific treatment in the Dermal Fillers and Botulinum Toxin market. The proliferation of social and mainstream media has had a massive impact on customers, encouraging them to go under the knife earlier to delay the onset of ageing as much as possible.

  (Added: Tue Feb 05 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Cosmetic and Aesthetic Surgeon - Harley Street Surgery’s practice is unique. We focus on natural form and beauty with a holistic approach; from diet and skin care, minimally invasive techniques, to extensive cosmetic surgery. This means providing youthful rejuvenation and natural-looking results that don’t look fake, or as if you had any work done at all i.e keep people guessing. Our favorite patient is the anxious first-timer. From the very start, our patients experience a highly personalized approach to achieving his or her goals. We take pride in providing knowledge and guidance in order to ensure patients feel comfortable and informed every step of the way. Our practice is different. We only recommend methods that we know work and will help you meet your goals with the least amount of downtime as possible. (Added: Tue Feb 05 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Scar Treatment Market Report 2018-2026 Focuses On Top Companies - Scar Treatment market Regional analysis:- North America is expected to be dominant in global scar treatment market over the forecast period. This is due to launch of new products in the region. For instance, in 2017, Herborium Group Inc., a botanical therapeutics company, launched Rejuvel 3D. This is a topical acne scar product, which has plant cells and antigravity technology that helps in reducing and eliminating acne scars, spots and marks, while moisturizing and rejuvenating the skin. Europe scar treatment market is expected to show significant growth over the forecast period, due to launch of new products for scar treatment by key players in the market. For instance, in 2017, Fagron NV, an innovative pharmaceutical compounding company launched Nourisil MD Silicone scar gel in the U.K. This silicone gel aids in flattening, smoothening, and softening of keloids, and hypertrophic scars due to its unique formula of five different silicones and vitamin E. Nourisil MD Silicone scar gel is a skin- friendly product and can aid in treating scars in children. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1993 For instance, in 2016, Win Medicare Ltd. launched Contractubex - a medical solution to treat scars. This product aids in treatment of normal wound scars by improving their appearance. It makes the scars smoother, more functional, elastic, strong, and less noticeable. Furthermore, collaborations between key players is expected to drive global scar treatment market growth. For instance, in February 2018, Sensus Healthcare Inc., a medical device company— collaborated with Birch BioMed Inc., a biomedical company, to treat and prevent scarring more effectively for patients who are afflicted with keloids. Approval of new products by FDA is also expected to drive growth of the scar treatment market. For instance, in 2013, Sensus Healthcare received approval from FDA for its SRT-100 device. The device utilizes sharp beam technology, which is a superficial radiotherapy innovation that first isolates and then targets the affected skin. This keloid scar removal treatment does not affect the surrounding and underlying healthy skin and tissues. Scar Treatment Market Key Players:- Key players operating in the global scar treatment market include Merz Inc., Lumenis Ltd., Smith & Nephew Plc., Sonoma Pharmaceuticals Inc., Enaltus LLC., Scarheal Inc., Molnlycke Healthcare, CCA Industries Inc., and Cynasure Inc. Market players are focusing on launching innovative products, in order to enhance their market share. For instance, in 2015, the editors of TotalBeauty.com recognized Mederma® PM Intensive Overnight Scar Cream, as breakthrough product. Mederma is a topical product, which aids in treating scars on the face and body due to injury, acne, surgery, and others. Furthermore, major companies are launching campaigns, in order to treat patients with scars and wounds. This is expected to aid in increasing customer base of the company. For instance, in 2016, Lumenis Ltd., an energy-based medical device company for aesthetic, surgical, and ophthalmology applications, launched a campaign -Restoring Heroes Foundation. This foundation helps in treating scars and wounds of American soldiers. Such campaigns are expected to fuel the scar treatment market growth. Click To Reading More On Scar Treatment Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com (Added: Tue Feb 05 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• AverickMedia Released Cardiologist Email List with Better Conversion Rates and ROI - Master the new wave of Marketing with AverickMedia Delivery-Driven Cardiologist Email Database AverickMedia one of the best email service provider announced the release of their highly verified Cardiologist Email Database that can channelize campaigns to foster global growth. This can help the b2b marketing becomes faster and easier. The segmented contact details of the healthcare specialist help you to achieve higher sales. Reaching the Cardiologist Specialist will be the solution for that AverickMedia offers the triple verified Cardiologist Email List. Marketing to healthcare providers become easy with their business to business email service. AverickMedia enables you to select the best healthcare professionals and decision-makers by providing the highly targeted cardiologist email addresses. To make direct contact with Cardiology professionals from the medical industry they offer Cardiologist Email Database this can be a reliable and affordable way. At AverickMedia, they make your efforts bear better business results and help you to connect with top business professionals. Marketers acquire the best data that will drive their campaigns to success with minimal cost and get better results. Reach the business marketers that really matters for your business to get high response rates and best results. About AverickMedia: AverickMedia provides detailed, accurate, and consistent business email database. They believe high-quality business data can discover business sales. Starting with highly targeted business prospects, you save time and money while increasing marketing effectiveness. When you buy a customized list of personalized contacts from AverickMedia, they guarantee that each contact is the right buyer you are looking for. With this Cardiologist Email List containing contact information for over 35,619 decision-makers in the cardiology industry marketers can conduct an email marketing campaign, direct mail campaign, fax broadcast, a telephone survey or a combination of channels for a more comprehensive business approach. Contact Information:- Call us: 1-281-407-7651 Email us: sales@averickmedia.com Website: http://www.averickmedia.com/ (Added: Tue Feb 05 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Anesthesia Laryngeal Masks Market Revenue Status and Outlook 2018-2026 - Anesthesia laryngeal mask is a medical device that keeps a patient’s airway open during anesthesia. This device maintains upper airway patency during general anesthesia or unconsciousness. A laryngeal mask has an airway tube that connects to an elliptical mask with cuff, which can be inflating type or self-sealing. It is also used to rescue airway in a failed intubation. Anesthesia laryngeal mask is a supragllotic airway device that is used in emergency conditions and anesthesia. This device allows for limited intermittent positive pressure ventilation. Read Report Overview: https://www.transparencymarketresearch.com/anesthesia-laryngeal-masks-market.html Increase in the number of surgeries and demand for disposable devices are the key drivers of the global anesthesia laryngeal masks market. According to the WHO, 226.4 million surgical procedures were performed globally in 2004 and the number increased to 312.9 million in 2012, an increase of 38.2%. Rise in prevalence of chronic diseases, increase in the geriatric population, and advancement in technology are the other factors that contribute to the growth of the global anesthesia laryngeal masks market. The number of people affected with chronic diseases continues to rise across the world. This, in turn, fuels the need for surgical procedures. Hence, increase in the incidence of chronic disorders that require surgeries is a key driver of the global anesthesia laryngeal masks market. According to the Centers for Disease Control and Prevention, deaths due to chronic diseases are more prevalent in the U.S., with heart diseases accounting for 635,260 and respiratory diseases accounting for 154,596 deaths in 2016. However, lack of skilled personnel to perform anesthesia and complications associated with anesthesia laryngeal masks are the major factors likely to restrain the global anesthesia laryngeal masks market. The global anesthesia laryngeal masks market can be segmented based on type, end-user, and region. In terms of type, the market can be bifurcated into disposable anesthesia laryngeal masks and reusable anesthesia laryngeal masks. The reusable anesthesia laryngeal masks segment dominated the global market in 2017 and is projected to sustain its position during the forecast period. This is attributed to lower operational cost than disposable masks. However, the disposable anesthesia laryngeal masks segment is anticipated to expand at a higher CAGR during the forecast period. This is due to low cost and user preference because of risk factors associated with reusable anesthesia laryngeal masks. The disposable anesthesia laryngeal masks segment can be classified into masks with endotracheal tube and masks with gastric suction channel. Based on end-user, the global anesthesia laryngeal masks market can be categorized into hospitals, ambulatory surgical centers, clinics, and others. Hospitals was the dominant segment in 2017. The segment is expected to expand at a high CAGR during the forecast period. Rise in the number of surgical procedures, well-equipped & qualified staff, and larger patient pool for surgical operations are the major factors driving the hospitals segment. In terms of region, the global anesthesia laryngeal masks market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017, followed by Europe. Increase in the geriatric population, rise in respiratory, orthopedic, and neurological diseases which require surgeries, government initiatives toward surgical procedures, and surge in awareness among people about health drive the anesthesia laryngeal masks market in the region. The anesthesia laryngeal masks market in Asia Pacific is likely to expand at a high CAGR in the next few years. This can be attributed to increase in number of surgical procedures, improving health care infrastructure, and advanced technologies in emerging countries in the region. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57237 The global anesthesia laryngeal masks market is highly fragmented due to presence of large number of multinational companies. Key players in the global anesthesia laryngeal masks market include GE Healthcare, Ambu A/S, Medline Industries, Inc., Becton, Dickinson and Company, Smiths Group plc, Hsiner Co., Ltd., Intersurgical, Inc., BLS Systems Limited, KindWell Medical, and Teleflex Incorporated. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Feb 05 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Advanced Therapies Equipment Market Statistical Analysis, Size, Share, and Forecast to 2026 - Advanced therapies equipment are innovative and cutting edge medical devices. These medical devices offer high efficacy levels, which has attracted significant attention and investments. New generation of medical devices such as surgical imaging devices are expected to be launched in the advanced therapies equipment market in the next few years. Technologies such as next generation image-guided therapy platform, which is capable of performing wide range of catheter-based procedures, bring revolutionary changes in the field of medical surgery, especially in minimally-invasive, by reducing errors and speeding up procedure time. Read Report Overview: https://www.transparencymarketresearch.com/advanced-therapies-equipment-market-global.html In terms of device type, the global advanced therapies equipment market can be classified into angio systems, C-arm systems, and others. The angio systems segment is projected to grow at a rapid pace during the forecast period. This is attributed to unparalleled performance with revolutionary X-ray imaging and unique sensitivity of ultra-low dosing imaging facility which helps perform minimally invasive procedures in a more convenient way. Based on application, the market can be categorized into pain management, cardiovascular, orthopedic, spine surgery, and others. The cardiovascular segment is expected to grow at a rapid pace due to high prevalence of cardiovascular diseases across the globe. In terms of end-user, the global advanced therapies equipment market can be divided into hospitals, diagnostic laboratories, and others. The hospitals segment is anticipated to expand at a high CAGR during the forecast period, as large number of patients prefer diagnosis of diseases in hospitals due to the availability of treatment and diagnostics under one roof. Advanced therapies equipment offer revolutionary treatments for a number of diseases such as cardiovascular, orthopedic, urology, and gastrointestinal. Rise in demand for minimally invasive procedures, which is emerging as the new standard in precision medicine, and increase in complexity of different surgical procedures that require complex advanced equipment are the major factors that drive the global advanced therapies equipment market. However, high price of the devices and increase in utilization rates for installed systems hamper the growth of the advanced therapies equipment market. In terms of region, the global advanced therapies equipment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. The region is projected to account for significant share of the global market during the forecast period, due to rise in prevalence of cardiovascular diseases. According to National Center for Health Statistic, 2011, heart disease is the leading cause of death in the U.S., and killing more than 600,000 Americans each year. Increase in demand for minimally invasive surgeries among the geriatric population is anticipated to augment the advanced therapies equipment market in Europe. Rise in prevalence of orthopedic disorders and cardiovascular diseases in countries such as India and China, availability of advanced devices, and increase in awareness about the advantages of minimally invasive surgery are likely to propel the market in Asia Pacific during the forecast period. Rapid rise in health care infrastructure and high prevalence of diseases such as cancer propel the advanced therapies equipment in Middle East & Africa. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57267 Key players operating in the global advanced therapies equipment market are Hologic, Inc., Siemens Healthineers, Medtronic, Canon Medical System Corporation, GE Healthcare, Koninkliike Philips, Shimadzu Corporation, and Aton GmbH, among others. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Feb 04 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Von Willebrand Disease Treatment Market Growth Analysis, Trends and Scope till 2026 - The von Willebrand factor (VWF) is a clotting protein. Von Willebrand factor's primary function is to bind to other proteins, in particular factor VIII, and is important in platelet adhesion to wound sites. Von Willebrand disease (VWD) is a genetic disorder caused by missing or defective von Willebrand factor (VWF). Von Willebrand disease is a chronic bleeding disorder, wherein blood does not clot well. Most people with the disease are born with it; however, its warning signs may not show up for years. Some people may suspect they have a bleeding disorder when they have heavy bleeding after a dental procedure or, for women, during a menstrual period. The most common sign of von Willebrand disease is abnormal bleeding. The four types of von Willebrand disease are type 1 von Willebrand disease, type 2 von Willebrand disease, type 3 von Willebrand disease, and acquired von Willebrand disease. Von Willebrand disease (VWD) is the most common cause of menorrhagia in women. Moreover, von Willebrand disease is common in developed countries such as the U.S. and economies in Western Europe. Around 16% to 37% women with high menstrual bleeding are diagnosed with Von Willebrand disease (VWD) in these regions. Physicians recommend the following blood tests for diagnosis of von Willebrand disease: von Willebrand factor antigen test, ristocetin cofactor activity test, factor VIII clotting activity test, and von Willebrand factor multimers test. Read Report Overview: https://www.transparencymarketresearch.com/von-willebrand-disease-treatment-market.html The global von Willebrand disease treatment market can be segmented based on disease type, drug type, distribution channel, and region. In terms of disease type, the global market can be classified into type 1 von Willebrand disease, type 2 von Willebrand disease, type 3 von Willebrand disease, and acquired von Willebrand disease. Type 1 von Willebrand disease is the most common type and is projected to account for the major share of the global market. Based on drug type, the global von Willebrand disease treatment market can be classified into desmopressin, replacement therapies, contraceptives, clot-stabilizing medications, and others. The desmopressin segment is anticipated to account for major von Willebrand disease treatment market share, as these drugs are used for long-term treatment of the disease. In terms of distribution channel, the global von Willebrand disease treatment market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies. Geographically, the global von Willebrand disease treatment market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to account for the leading share of the global von Willebrand disease treatment market due to favorable reimbursement scenario and higher health care spending. Europe is likely to be the second largest market for von Willebrand disease treatment during the forecast period due to rise in awareness about new treatment options and developed regulatory framework. The von Willebrand disease treatment market in Asia Pacific is projected to grow at a rapid pace in the near future, driven by rise in prevalence of blood cloth diseases and improving health care infrastructure in the region. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57729 Key players operating in the global von Willebrand disease treatment market are Octapharma AG, Grifols, S.A., Shire plc, Pfizer, Inc., Novo Nordisk A/S, Bayer AG, Sanofi, Kedrion S.p.A, and CSL Behring, among others. Expansion of product portfolio through mergers and acquisitions is a key strategy followed by these market players. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Feb 04 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Anesthesia Ventilators Market Current Trends and Future Aspect Analysis 2026 - Anesthesia ventilators are an important part of anesthesia workstation. Anesthesia ventilators have either double circuit (bellows design) or single circuit (piston configuration). Double circuit ventilators are most commonly used in modern anesthesia. These ventilators comprise pressurized driving gas that compresses bellows, which in turn deliver ventilation to patients. A computer controlled motor is used in single circuit anesthesia ventilators instead of compressed gas to deliver gas in the breathing system. Read Report Overview: https://www.transparencymarketresearch.com/anesthesia-ventilators-market.html The global anesthesia ventilators market is driven by increase in the number of surgeries, high demand for development of enhanced anesthesia delivery machines, rise in prevalence of chronic conditions, and technological advancements. According to the Centers for Disease Control and Prevention (CDC), approximately 234 million surgical procedures are performed globally each year. One in every 25 people is undergoing surgery at any given time. China conducts the largest number of surgeries, followed by Russia and India. The U.S. alone performs 39 million surgeries each year, which include 1.01 million cardiac catheterizations, 1.1 million endoscopic procedures of the small intestine (with or without biopsy), 499,000 endoscopic procedures of the large intestine (with or without biopsy), 395,000 coronary artery bypass grafts (CABG), 719,000 knee replacements, and 332,000 total hip replacements. Global cardio-thoracic MIS procedures stood at around 10 million in 2011 and are estimated to reach 14 million by 2020. Nine million gastro-intestinal procedures were performed in 2011 which are likely to reach around 13 million by 2020. Orthopedic procedures were reported to be around 5 million in 2011 and projected to increase to 7 million by 2020. These statistics indicate a growth trend in the number of surgeries globally. Hence, rise in the number of surgeries drives the global anesthesia ventilators market. Additionally, increase in adoption of technologically advanced health care devices, increase in the geriatric population, and advancements in health care are projected to boost the growth of the global anesthesia ventilators market in the next few years. However, lack of awareness about controlled anesthesia delivery and high prices due to tax reforms are expected to restrain the anesthesia ventilators market during the forecast period. Government funding in emerging markets, low cost manufacturing destinations, and high adoption of Anesthesia Information Management Systems (AIMS) and its integration with electronic health record (EHR) are likely to augment the global market from 2018 to 2026. The global anesthesia ventilators market can be segmented based on mode of ventilation, product type, end-user, and region. In terms of mode of ventilation, the market can be classified into synchronized intermittent mandatory ventilation, pressure-control ventilation, and pressure-support ventilation. Based on product type, the global anesthesia ventilators market can be bifurcated into bellows ventilators and piston ventilators. In terms of end-user, the global anesthesia ventilators market can be divided into hospitals, critical care, and ambulatory surgical centers. In terms of region, the global anesthesia ventilators market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America led the global market in 2017 owing to well-developed health care systems. The anesthesia ventilators market in Europe is stable due to no significant changes in taxes on medical devices in the past few years. The anesthesia ventilators market is likely to be driven by high demand in ambulatory care centers. Asia Pacific held the third largest market share in 2017. This is attributed to technological advancements in anesthesia ventilators, rise in population, especially the geriatric population, and increase in the number of surgical procedures performed every year, especially in China and India. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57954 Key players operating in the global anesthesia ventilators market include Drägerwerk AG, GE Healthcare, Penlon, CareFusion, JD Medical, Gradian Health Systems, SunMed, OES Medical, Medtronic plc, and Hamilton Medical. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Feb 04 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 ... [>>]